Drug Delivery (Dec 2022)

Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin

  • Yixing Lu,
  • Liuye Yang,
  • Wanying Zhang,
  • Shiting Xie,
  • Feifei Zhao,
  • Xianfeng Peng,
  • Zonghua Qin,
  • Dongping Zeng,
  • Zhenling Zeng

DOI
https://doi.org/10.1080/10717544.2022.2118400
Journal volume & issue
Vol. 29, no. 1
pp. 2824 – 2830

Abstract

Read online

Isopropoxy benzene guanidine (IBG) is a novel substituted benzene guanidine analogue with antibacterial activity against multidrug-resistant bacteria. However, the bioavailability of IBG is not optimal due to its finite aqueous solubility, thus hampering its potential therapeutic exploitation. In this study, we prepared IBG/hydroxypropyl-β-CD (IBG/HP-β-CD) complex, and characterized it by differential scanning calorimetry, Fourier transform infrared spectroscopy, powder X-ray diffraction, and scanning electron microscopy. Physicochemical characterization indicated that the crystal morphology of IBG transformed into an amorphous state, thus forming IBG/HP-β-CD inclusion complexes. Complexation with HP-β-CD significantly improve the aqueous solubility, pharmaceutical properties, absorption, and bioavailability of IBG.

Keywords